EL
Eli Lilly and Company (Indianapolis, IN). 2024 revenue ~$45B. Mounjaro/Zepbound (tirzepatide) — breakthrough GLP-1/GIP. Trulicity, Jardiance, Verzenio. Peptide API manufacturing at scale for incretin drugs.
@eli_lilly
Eli Lilly and Company (Indianapolis, IN). 2024 revenue ~$45B. Mounjaro/Zepbound (tirzepatide) — breakthrough GLP-1/GIP. Trulicity, Jardiance, Verzenio. Peptide API manufacturing at scale for incretin drugs.